A. Nazari , S. Sager , S. Schenke , L. Uslu Beşli , C. Samancı , T. Öztürk , H.B. Sayman
{"title":"The contribution of PET/MRI in benign/malignant nodule separation in thyroid incidentalomas detected in FDG PET/CT imaging","authors":"A. Nazari , S. Sager , S. Schenke , L. Uslu Beşli , C. Samancı , T. Öztürk , H.B. Sayman","doi":"10.1016/j.rceng.2025.502333","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Incidentalomas of the thyroid gland are frequently observed in oncological patients undergoing FDG PET/CT imaging for staging or treatment response assessment. This study aims to investigate the utility of SUVmax and ADC values measured by PET/MRI in distinguishing between benign and malignant thyroid nodules.</div></div><div><h3>Materials and methods</h3><div>We selected 108 patients (72 females, 36 males; mean age 54 ± 12 years) who underwent routine oncological FDG PET/CT scans for staging or treatment response assessment, with nodule sizes greater than 1 cm. A one-bed neck PET/MRI scan followed the whole-body PET/CT. SUVmax values were measured, and ADC maps were created using DWI with b factors of 50 and 1000 s/mm<sup>2</sup>. SUVmax and ADC values were correlated with FNAC results.</div></div><div><h3>Results</h3><div>FNAC results revealed 76 (70.4%) benign and 32 (29.6%) malignant nodules among the 108 patients. The mean SUVmax of malignant nodules was significantly higher than that of benign nodules (10.6 ± 8.3 vs. 5.94 ± 5.2, <em>p</em> < 0.001). Similarly, the mean ADC value was lower in malignant nodules compared to benign ones (1.4 ± 0.6 × 10<sup>−3</sup> mm<sup>2</sup>/s vs. 1.8 ± 0.4 × 10<sup>−3</sup> mm<sup>2</sup>/s; <em>p</em> < 0.001). A significant but weak correlation was found between FNAC results and mean SUVmax (<em>r</em> = 0.335), as well as a significant weak negative correlation with mean ADC values (<em>r</em> = −0.355). Using a cut-off value of 6 for SUVmax and 1.56 × 10<sup>−3</sup> mm<sup>2</sup>/s for ADC, the sensitivity, specificity, and accuracy for SUVmax were 68.7%, 73.6%, and 72.1%, respectively, while for ADC, they were 71.8%, 69.7%, and 70.4%, respectively. The PET/MRI system demonstrated a relative sensitivity, specificity, accuracy, PPV, and NPV of 90.62%, 51.32%, 62.96%, 43.94%, and 92.86%.</div></div><div><h3>Conclusion</h3><div>This study is one of the first in the literature to explore the use of FDG PET/MRI, a single-stop device, in distinguishing between benign and malignant thyroid nodules with high sensitivity and NPV.</div></div>","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":"225 7","pages":"Article 502333"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista clinica espanola","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2254887425000670","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction and objectives
Incidentalomas of the thyroid gland are frequently observed in oncological patients undergoing FDG PET/CT imaging for staging or treatment response assessment. This study aims to investigate the utility of SUVmax and ADC values measured by PET/MRI in distinguishing between benign and malignant thyroid nodules.
Materials and methods
We selected 108 patients (72 females, 36 males; mean age 54 ± 12 years) who underwent routine oncological FDG PET/CT scans for staging or treatment response assessment, with nodule sizes greater than 1 cm. A one-bed neck PET/MRI scan followed the whole-body PET/CT. SUVmax values were measured, and ADC maps were created using DWI with b factors of 50 and 1000 s/mm2. SUVmax and ADC values were correlated with FNAC results.
Results
FNAC results revealed 76 (70.4%) benign and 32 (29.6%) malignant nodules among the 108 patients. The mean SUVmax of malignant nodules was significantly higher than that of benign nodules (10.6 ± 8.3 vs. 5.94 ± 5.2, p < 0.001). Similarly, the mean ADC value was lower in malignant nodules compared to benign ones (1.4 ± 0.6 × 10−3 mm2/s vs. 1.8 ± 0.4 × 10−3 mm2/s; p < 0.001). A significant but weak correlation was found between FNAC results and mean SUVmax (r = 0.335), as well as a significant weak negative correlation with mean ADC values (r = −0.355). Using a cut-off value of 6 for SUVmax and 1.56 × 10−3 mm2/s for ADC, the sensitivity, specificity, and accuracy for SUVmax were 68.7%, 73.6%, and 72.1%, respectively, while for ADC, they were 71.8%, 69.7%, and 70.4%, respectively. The PET/MRI system demonstrated a relative sensitivity, specificity, accuracy, PPV, and NPV of 90.62%, 51.32%, 62.96%, 43.94%, and 92.86%.
Conclusion
This study is one of the first in the literature to explore the use of FDG PET/MRI, a single-stop device, in distinguishing between benign and malignant thyroid nodules with high sensitivity and NPV.